Earlier this week, Axsome (NASDAQ: AXSM ) published topline data from the open-label, follow on phase 3 study of AXS-12 (reboxetine) for the treatment of narcolepsy patients with cataplexy. The trial met its primary endpoint of change in frequency of weekly cataplexy attacks fromAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticke ...

On Tuesday, Axsome Therapeutics Inc AXSM said AXS-12 statistically significantly reduced the frequency of cataplexy attacks compared to placebo (p=0.017, primary endpoint) in Phase 3 ENCORE trial.AXS-12 was also well tolerated with long-term dosing, and its safety profile was consistent with that observed in previously completed trials.The primary endpoint was achieved with patients randomized to switch to placebo experiencing a mean increase of 10.29 cataplexy attacks per week compared to a mean increase o ...

Core Viewpoint - AXIS Capital Holdings (AXS) has shown significant stock performance, with a year-to-date increase of 64.7%, outperforming the industry and broader market indices, driven by a strong product portfolio and solid financial metrics [1]. Company Performance - AXS has a market capitalization of $7.6 billion and an average trading volume of 0.5 million shares over the last three months [1]. - The stock is trading above its 50-day moving average and is near its 52-week high, indicating a bullish trend [4]. Analyst Sentiment - The average price target for AXS is $96.57 per share, suggesting an 8.8% upside from the recent closing price [5]. - Recent estimate revisions show three out of four analysts raised their earnings estimates for 2024 and 2025, reflecting positive analyst sentiment [6]. Growth Drivers - AXIS Capital is focusing on growth areas such as wholesale insurance and lower middle markets, while managing risk exposure effectively [7]. - The Insurance segment is expected to see net premiums written (NPW) grow at a three-year CAGR of 7.1% by 2026, while the Reinsurance business is projected to grow at a CAGR of 7.2% [8]. Digital and Operational Efficiency - The company is enhancing its digital capabilities to drive growth in smaller accounts and aims to achieve a general and administrative ratio of less than 11% by 2026 [9]. Earnings Projections - The Zacks Consensus Estimate for 2024 earnings is $10.89, reflecting a 10.6% increase, with revenues expected to rise to $6.1 billion [11]. - For 2025, earnings are estimated at $11.65, indicating a 7% increase on revenues of $6.8 billion [11]. Dividend and Returns - AXIS Capital has a strong dividend history, having increased its dividend for 18 consecutive years, with a current yield of 2.3% [12]. - The trailing 12-month return on equity is 19.2%, significantly higher than the industry average of 7.6% [13]. Valuation - AXS shares are trading at a price-to-book multiple of 1.4, below the industry average of 1.6, presenting a favorable entry point for investors [15]. - The company has a Value Score of A, indicating attractive valuation compared to peers [15][16]. Strategic Positioning - AXIS Capital is repositioning its portfolio to enhance efficiencies and improve underwriting profitability, positioning itself for future growth [17]. - The company has a VGM Score of A, reflecting its strong fundamentals [17]. Investment Consideration - Given its impressive dividend history, solid growth projections, positive analyst sentiment, and attractive valuations, AXS is considered a worthy addition to investment portfolios [18].

For those looking to find strong Finance stocks, it is prudent to search for companies in the group that are outperforming their peers. Axis Capital (AXS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Finance sector should help us answer this question.Axis Capital is one of 871 companies in the Finance group. The Finance group c ...

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts ...

Investors with an interest in Insurance - Property and Casualty stocks have likely encountered both Axis Capital (AXS) and Cincinnati Financial (CINF) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate r ...

Financial Data and Key Metrics Changes - The company reported a net income available to common shareholders of $173 million or $2.04 per diluted common share, resulting in an annualized ROE of 13% [33] - Book value per diluted common share increased to $64.65 at quarter end, reflecting a nearly 20% year-to-date growth [33] - Operating income was $230 million or $2.71 per diluted common share, leading to an annualized operating ROE of 17.3% [33] - The combined ratio for the quarter was 93.1%, despite the impact of Hurricanes Helene and Beryl [34] - The current accident year loss ratio ex-CAT and weather was 55.7% [34] Business Line Data and Key Metrics Changes - The insurance segment achieved gross premiums written of $1.5 billion, a 4.7% increase compared to the prior year [42] - The combined ratio for the insurance segment was 90.4%, including 7% of CAT and weather-related losses, resulting in $99 million of underwriting income [46] - In the reinsurance segment, gross premiums decreased by 8.7% in the quarter, but year-to-date growth was up 5% [47][48] - The reinsurance combined ratio was 91.4%, with an ex-CAT and weather loss ratio of 66% [49] Market Data and Key Metrics Changes - The company reported a 5.8% group-level catastrophe ratio against an estimated $40 billion in industry losses [8] - The North American strategic initiatives are gaining traction, with the U.S. lower middle market units producing 17% growth over the prior year quarter [15] - The company noted increased competition in the marine, aviation, and property lines within global markets [16] Company Strategy and Development Direction - The company continues to focus on premium adequate short tail lines that align with underwriting capabilities and broker needs [11] - The strategic principles shared at the investor day are gaining traction, emphasizing profitable growth and expense management [7] - The company is investing in technology and talent, including partnerships with AI-driven platforms to enhance submission and underwriting processes [29][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to generate profitable growth despite a dynamic market environment [28] - The company is optimistic about leveraging its diverse product set and distribution channels [20] - Management highlighted the importance of maintaining a disciplined approach in competitive markets, particularly in property and casualty lines [22][23] Other Important Information - The company returned $77 million to shareholders through dividends and share repurchases [54] - The effective tax rate for the quarter was 21%, higher than the historical rate due to strong profitability in higher tax geographies [53] Q&A Session Summary Question: Concerns about reserving and long tail casualty lines - Management conveyed confidence based on the first nine months of reported results and actions taken in 2023 [56][57] - A full reserve review will be conducted at year-end 2024, with a focus on the underlying lines of business [58][60] Question: Confidence in property market growth - Management cited portfolio construction, geographic spread, and premium adequacy as factors supporting continued growth in the property business [62] Question: Core loss ratio in insurance - The increase in the core loss ratio was attributed to prudence rather than negative trends [66] Question: Cyber insurance growth outlook - Management acknowledged a short-term hit on written premiums but expressed confidence in long-term growth opportunities [70] Question: Expectations for premium growth in 2025 - Management emphasized a focus on profitability over premium growth, with confidence in the ability to grow the business in attractive markets [80]

AXIS Capital Holdings Limited (AXS) posted third-quarter 2024 operating income of $2.71 per share, beating the Zacks Consensus Estimate by 8.4%. The bottom line increased 16% year over year.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The insurer’s results reflected improved net investment income and higher premiums, offset by poor underwriting income and higher expenses.Quarterly Operational Update  Total operating revenues of $1.5 billion beat the Zacks Consensus Estimate by 0. ...

Axis Capital (AXS) reported $1.58 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 6.2%. EPS of $2.71 for the same period compares to $2.34 a year ago. The reported revenue represents a surprise of +0.40% over the Zacks Consensus Estimate of $1.57 billion. With the consensus EPS estimate being $2.50, the EPS surprise was +8.40%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St ...

Axis Capital (AXS) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.50 per share. This compares to earnings of $2.34 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 8.40%. A quarter ago, it was expected that this insurance company would post earnings of $2.52 per share when it actually produced earnings of $2.93, delivering a surprise of 16.27%. Over the last four quarters, the co ...